偶発的なCOL4A5変種と関連した早期呼吸器不全による遺伝性ミオパシー:症例報告
Ursula Abu Nahla1, Rahaf Bleibel1, Mai Arafeh1
1Department of Pediatrics, Hebron University, Hebron, West Bank, State of Palestine, hebron.edu.
Case reports in genetics
|February 13, 2026
まとめ
早期呼吸機能不全 (HMERF) による遺伝性筋病症は,TTN遺伝子変異によって引き起こされる珍しい遺伝疾患です. ゲノム検査により,進行的な弱さや呼吸器系の問題のある患者でHMERFが確認されました.
科学分野:
- 神経学 神経学とは
- 遺伝学 遺伝学とは
- 珍しい病気 珍しい病気
背景:
- 早期呼吸機能不全 (HMERF) による遺伝性ミオパシーは,まれな自己相性優位性疾患である.
- TTN変種は,HMERFの既知の原因である.
- COL4A5変異は,X関連アルポート症候群と関連しています.
研究 の 目的:
- ゲノム検査で診断されたHMERFの症例を提示します.
- 異常な神経筋肉疾患における全エクソームシーケンシングの診断的有用性を強調する.
- 偶然の遺伝的発見の解釈について議論する.
主な方法:
- 臨床検査と家族歴.
- 磁気共鳴画像 (MRI) と針用電気ミオグラフィ (EMG).
- 遺伝子変異の識別のための全エクソームシーケンシング (WES).
主要な成果:
- 34歳の男性に,下肢の進行的な弱さ,歩行障害,夜間低呼吸症候群が現れた.
- WESは病原性TTN変種 (c.95126C>G,p.Pro31709Arg) を特定し,HMERF.を確認した.
- 偶発的な半導体COL4A5変種 (c.4891C>T,p.Arg1631Cys) が検出されたが,臨床的相関関係がなかった.
結論:
- このケースは,遺伝的証拠を持つ古典的なHMERF現象型を確認しています.
- ゲノム検査は,非典型的な神経筋疾患の診断に不可欠です.
- 偶然の遺伝的発見は,慎重に臨床的相関と解釈を必要とします.
関連する概念動画
Acute Respiratory Failure-I
1.1K
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
1.1K
Acute Respiratory Failure-II
1.2K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.2K
Acute Respiratory Failure-V
515
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
515
Acute Respiratory Failure-III
943
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
943
Acute Respiratory Failure-IV
581
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
581
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
636
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
636


